he purpose of this report was to update the 2006 International League Against Epilepsy (ILAE) report and identify the level of evidence for long-term efficacy or effectiveness for antiepileptic drugs (AEDs) as initial monotherapy for patients with newly diagnosed or untreated epilepsy. All applicable articles from July 2005 until March 2012 were identified, evaluated, and combined with the previous ysis (Glauser et al., 2006) to provide a comprehensive update.
The prior ysis methodology was utilized with three modifications: (1) the detectable noninferiority boundary approach was dropped and both failed superiority studies and prespecified noninferiority studies were yzed using a noninferiority approach, (2) the definition of an adequate comparator was clarified and now includes an absolute minimum point estimate for efficacy/effectiveness, and (3) the relationship table between clinical trial ratings, level of evidence, and conclusions no longer includes a recommendation column to reinforce that this review of efficacy/evidence for specific seizure types does not imply treatment recommendations.
This evidence review contains one clarification: The commission has determined that class I superiority studies can be designed to detect up to a 20% absolute (rather than relative) difference in the point estimate of efficacy/effectiveness between study treatment and comparator using an intent-to-treat ysis. Since July, 2005, three class I randomized controlled trials (RCT) and 11 class III RCTs he been published. The combined ysis (1940-2012) now includes a total of 64 RCTs (7 with class I evidence, 2 with class II evidence) and 11 meta-yses.
New efficacy/effectiveness findings include the following: levetiracetam and zonisamide he level A evidence in s with partial onset seizures and both ethosuximide and valproic acid he level A evidence in children with childhood absence epilepsy.
There are no major changes in the level of evidence for any other subgroup. Levetiracetam and zonisamide join carbamazepine and phenytoin with level A efficacy/effectiveness evidence as initial monotherapy for s with partial onset seizures. Although ethosuximide and valproic acid now he level A efficacy/effectiveness evidence as initial monotherapy for children with absence seizures, there continues to be an alarming lack of well designed, properly conducted epilepsy RCTs for patients with generalized seizures/epilepsies and in children in general.
These findings reinforce the need for multicenter, multinational efforts to design, conduct, and yze future clinically relevant adequately designed RCTs. When selecting a patient's AED, all relevant variables and not just efficacy and effectiveness should be considered.
查看离散地址
上一页:哪些抗菌药物可诱发抑郁症?
- 2022-04-282013年该协会抗癫痫联合会抗癫痫药使用指南
- 2022-02-0720130301山东湖南卫视养生节目:安晓光谈癫痫病病因
- 2021-12-27成年癫痫病成因有哪些
- 2021-12-20具体内容的癫痫病病因有哪些
- 2019-04-22焦作那家医院治癫痫好
- 白癜风光疗有很多方法 因地制宜教你选择
- 许多女性可能不太了解慢性附件炎,其危害不亚于慢性盆腔炎
- 红辣椒怎么腌好吃 孕妇吃辣椒的注意事项
- 通过尿色自测健康状况(2)
- 注射激素会导致外周色素减少和萎缩
- 老人握手的原因是什么 如何治疗老人握手
- 骑自行车的好处和坏处 如何正确购买山地自行车
- 北京大学人民医院第九届男性健康沙龙
- 玫瑰精油的美白效果 怎么办?
- 一种吃大蒜的效果堪比人参
- 2018 KSOG立场声明:双侧输卵管切除术降低女性卵巢癌/输卵管癌/腹膜癌的平均风险
- J Endod:WeOne和WeOne Gold模拟临床应用后的结构特征和扭转阻力评估
- 男性胀痛三年,羞于就医 专家:男性也有乳腺疾病
- 包皮切除术怎么样?
- 继发性痛经
- Autoimmun Rev:心肌炎是一种系统性免疫介导性疾病:发病率、特征和预后
- Sci Rep:成人睾丸中内源性素系统成分的特征和定位
- Radiology:MRI?Dixon脂肪定量技术在乳糜液中的应用
- 综述:癫痫持续状态诊治最新进展
- A&R: Semaphorin3B 在血清诱导的关节炎模型中发挥核心作用,减少类风湿性关节炎患者
- 著名女演员愤怒地告诉莆田妇科医院 要求在全国媒体上公开道歉
- 白癜风症状 身体出现白斑时要小心
- 小便疼痛
- 精囊炎的症状是什么?
- 按摩手法 不同的治疗方法
- Cell Death Dis:SPATS2调节细胞周期,促进肝癌的发生和发展
- 荣获精鼎医药Scrip最佳合同研究组织称号
- 怎么治继发性羊癫疯 羊癫疯治疗步骤有什么
- 癫痫病是怎么引起的病变
- 癫痫的治疗要多少钱 癫痫需要要用哪些检查
- 癫痫病的病变
- 羊癫疯治疗方法有哪些 五个治疗方法优点好
- 引起癫痫病的主要病征是什么
- 脑瘫引起的癫痫要怎么外科手术?
- 顽固性癫痫病的病征
- 初期癫痫病应该采行什么方法来治疗呢
- 癫痫病的性疾病有什么
- 羊角风的诊疗对治疗会有什么影响
- 癫痫病的高血压有哪些呢
- 治疗癫痫病要花费多少钱 做好卫生也会减少费用